Binance's Bitcoin funding rate fell to -0.0073%, indicating increased demand for short positions in the derivatives market. This shift comes after US consumer and producer price indexes exceeded expectations, raising concerns about further Federal Reserve rate hikes. Bitcoin's price retreated after briefly surpassing $87,000, with a similar funding rate pattern last seen in June when Bitcoin was around $62,000. These developments suggest cautious sentiment among traders amid inflation and monetary policy uncertainties.
Binance Bitcoin funding rate developments are presented here with Pluang market data as of Oct 16, 2026 19:51 WIB. Among 50 major cryptocurrencies priced on Pluang, 44 rose and 5 fell today. Notable movers include EGLD at Rp67.863 with a 7.58% increase and 100% buy order activity, AVAX at Rp184.198 with a 7.13% rise and 91% buy orders, and VET at Rp128 with a 7.01% gain but 60% sell order activity.
NeOnc Technologies reported early clinical improvement in a critically ill three-year-old boy with an aggressive brain tumor treated with investigational intranasal NEO100 under compassionate use in Abu Dhabi. The child is now breathing independently...
TransUnion's Branded Call Display, a solution that helps consumers identify legitimate callers and avoid robocall fraud, has been named one of TIME's Best Inventions of 2026 in the Connectivity & Communication category. The technology displays a busi...
La Rosa Holdings Corp. will change its name to Stratum Holdings Corp. on October 19, 2026, reflecting its shift from real estate services to an AI infrastructure company specializing in GPU leasing and high-performance computing. The company recently...
ASUS has released the ProArt P16 and P14 laptops in Canada, powered by NVIDIA RTX Spark technology. These laptops feature up to 128GB of unified memory and advanced AI capabilities designed for creators, AI developers, and workflow builders, enabling...
OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG int...
